Despite the many basic research discoveries in genetics, relatively few gene-based treatments, drugs, or preventative measures have been developed. One way to bridge this gap may be for industry, academia, and government to develop partnerships that share resources while distributing risk. However, intellectual property protections and other barriers can inhibit collaborative efforts. The Institute of Medicine held a workshop on July 22, 2010, to explore these issues and develop solutions.
1 Front Matter; 2 1 Introduction; 3 2 A Lesson About Precompetitive Collaboration; 4 3 Requisites for Successful Precompetitive Collaboration; 5 4 Frameworks for Collaboration; 6 5 The Use of Biospecimens in Precompetitive Collaborations; 7 6 Ethical Challenges in the Use of Biospecimens; 8 7 Toward Developing a Cultural, Legal, and Behavioral Framework for Precompetitive Collaboration; 9 References; 10 Appendix A: Workshop Agenda; 11 Appendix B: Speaker Biographical Sketches
and Medicine National Academies of Sciences, Engineering, Institute of Medicine, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Clare Stroud, Sheena Posey Norris, Lisa Bain
National Academy of Engineering, National Academy of Sciences, Policy and Global Affairs, Institute of Medicine, and Public Policy Committee on Science, Engineering, Panel on Scientific Communication and National Security
Institute of Medicine, Division of Health Promotion and Disease Prevention, Division of Health Sciences Policy, Committee for Evaluating Medical Technologies in Clinical Use
Center for Medical Technology Policy, Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Steve Olson, Adam C. Berger
Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Steve Olson, Sarah H. Beachy, Samuel G. Johnson, Adam C. Berger
Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Adam C. Berger, Steve Olson, Samuel G. Johnson, Sarah H. Beachy
Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Adam C. Berger, Steve Olson, Samuel G. Johnson, Sarah H. Beachy
Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Adam C. Berger, Steve Olson, Samuel G. Johnson, Sarah H. Beachy
Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Steve Olson, Adam C. Berger, Sarah H. Beachy